![]() |
|
|
Vol. 286, Issue 2, 1074-1085, August 1998
Division of Neurotoxicology, National Center for Toxicological
Research, Jefferson, Arkansas (J.F.B., P.C.);
Department of Surgery,
University of Arkansas Medical Center, Little Rock, Arkansas (L.T.F.);
and
Department of Pharmacology and Physiology and the Neurosciences
Program, University of Rochester Medical Center, Rochester, New York
(K.N.C., C.A.O., C.R.S., A.W.T.)
Four injections (intraperitoneal) of 3 mg/kg amphetamine (2 hr apart)
produced pronounced hyperthermia and sustained decreases in dopamine
levels and tyrosine hydroxylase (TH) protein levels in the striatum of
15-month-old male rats. A partial recovery of striatal dopamine levels
was observed at 4 months after amphetamine. In contrast, TH mRNA and TH
protein levels in the midbrain were unaffected at all time points
tested up to 4 months after amphetamine treatment. The number of
TH-immunopositive cells in the midbrain was also unchanged at 4 months
after amphetamine, even though the number of TH-positive axons in the
striatum remained dramatically decreased at this time point.
Interestingly, TH-immunopositive cell bodies were observed 4 months
after amphetamine in the lateral caudate/putamen, defined anteriorly by
the genu of the corpus collosum and posteriorly by the junction of the
anterior commissures; these striatal TH-positive cells were not
observed in saline- or amphetamine-treated rats that did not become
hyperthermic. In addition, low levels (orders of magnitude lower than
that present in the midbrain) of TH mRNA were detected using reverse
transcription-polymerase chain reaction in the striatum of these
amphetamine-treated rats. Our results suggest that even though there is
a partial recovery of striatal dopamine levels, which occurs within 4 months after amphetamine treatment, this recovery is not associated
with increased TH gene expression in the midbrain. Furthermore, new
TH-positive cells are generated in the striatum at this 4-month time
point.
This article has been cited by other articles:
![]() |
X. Chen, L. Xu, P. Radcliffe, B. Sun, and A. W. Tank Activation of Tyrosine Hydroxylase mRNA Translation by cAMP in Midbrain Dopaminergic Neurons Mol. Pharmacol., June 1, 2008; 73(6): 1816 - 1828. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Advokat Literature Review: Update on Amphetamine Neurotoxicity and Its Relevance to the Treatment of ADHD J Atten Disord, July 1, 2007; 11(1): 8 - 16. [Abstract] [PDF] |
||||
![]() |
T. E. Nordahl, R. Salo, Y. Natsuaki, G. P. Galloway, C. Waters, C. D. Moore, S. Kile, and M. H. Buonocore Methamphetamine Users in Sustained Abstinence: A Proton Magnetic Resonance Spectroscopy Study Arch Gen Psychiatry, April 1, 2005; 62(4): 444 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sun, X. Chen, L. Xu, C. Sterling, and A. W. Tank Chronic Nicotine Treatment Leads to Induction of Tyrosine Hydroxylase in Locus Ceruleus Neurons: The Role of Transcriptional Activation Mol. Pharmacol., October 1, 2004; 66(4): 1011 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sun, C. R. Sterling, and A. W. Tank Chronic Nicotine Treatment Leads to Sustained Stimulation of Tyrosine Hydroxylase Gene Transcription Rate in Rat Adrenal Medulla J. Pharmacol. Exp. Ther., February 1, 2003; 304(2): 575 - 588. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Thiruchelvam, E. K. Richfield, R. B. Baggs, A. W. Tank, and D. A. Cory-Slechta The Nigrostriatal Dopaminergic System as a Preferential Target of Repeated Exposures to Combined Paraquat and Maneb: Implications for Parkinson's Disease J. Neurosci., December 15, 2000; 20(24): 9207 - 9214. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Cass and M. W. Manning Recovery of Presynaptic Dopaminergic Functioning in Rats Treated with Neurotoxic Doses of Methamphetamine J. Neurosci., September 1, 1999; 19(17): 7653 - 7660. [Abstract] [Full Text] [PDF] |
||||